← Eichor
Study identifier: NCT06486012 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients

Condition: Diabetes Mellitus, Type 2 · Pre-diabetes · Periodontal Diseases  ·  Sponsor: Wellbeing Services County of Pirkanmaa

PhaseNA
Planned participants150
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is an investigator-initiated clinical study to establish easy referral and access for diabetic patients from primary health care to oral health care facilities for preventive oral care, periodontal assessment, and treatment, and to investigate the impact of regular home use of aPDT medical device on plaque control and gingival health, when used as an adjunct treatment to standard oral hygiene, and the effect on diabetes control in patients with the risk of periodontal disease, compared to a standard home care oral hygiene regimen.

This description comes directly from the study's public registry record.

Talk to the study team

Miia Ehrnrooth  ·  +358406615307  ·  miia.ehrnrooth@mehilainen.fi

Mikko Kylmänen, Master of Health Care  ·  mikko.kylmanen@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Wellbeing Services of County PirkanmaaTampere, Pirkanmaa, FinlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06486012